BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19208095)

  • 1. Advances in the understanding of dyskeratosis congenita.
    Walne AJ; Dokal I
    Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
    Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of dyskeratosis congenita.
    Mason PJ; Bessler M
    Cancer Genet; 2011 Dec; 204(12):635-45. PubMed ID: 22285015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
    Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
    Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita.
    Dokal I
    Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
    Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
    Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
    Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
    Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
    Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
    Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis congenita as a disorder of telomere maintenance.
    Nelson ND; Bertuch AA
    Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between DNA methylation and telomere length in dyskeratosis congenita.
    Gadalla SM; Katki HA; Shebl FM; Giri N; Alter BP; Savage SA
    Aging Cell; 2012 Feb; 11(1):24-8. PubMed ID: 21981348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility gene card for: Dyskeratosis congenita - update 2015.
    Dokal I; Vulliamy T; Mason P; Bessler M
    Eur J Hum Genet; 2015 Apr; 23(4):. PubMed ID: 25182133
    [No Abstract]   [Full Text] [Related]  

  • 18. Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
    Dokal I; Vulliamy T
    Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.
    Savage SA; Giri N; Baerlocher GM; Orr N; Lansdorp PM; Alter BP
    Am J Hum Genet; 2008 Feb; 82(2):501-9. PubMed ID: 18252230
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.